| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/17/2011 | US20110064760 Polypeptides comprising epitopes of hiv gp41 and methods of use |
| 03/17/2011 | US20110064757 Nucleic acid molecules and polypeptides for immune modulation |
| 03/17/2011 | US20110064756 Novel sequences of brachyspira, immunogenic compounds, methods for preparation and use thereof |
| 03/17/2011 | US20110064755 Methods for producing block copolymer/amphiphilic particles |
| 03/17/2011 | US20110064754 Immunoconjugates Comprising Poxvirus-Derived Peptides and Antibodies Against Antigen-Presenting Cells for Subunit-Based Poxvirus Vaccines |
| 03/17/2011 | US20110064753 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 03/17/2011 | US20110064752 Extracellular targeted drug conjugates |
| 03/17/2011 | US20110064749 Compositions comprising immunoreactive reagents and saponins, and methods of use thereof |
| 03/17/2011 | US20110064745 Therapeutic Antibodies, Antibody Fragments And Antibody Conjugates |
| 03/17/2011 | US20110064734 Prevention and treatment of amyloidogenic disease |
| 03/17/2011 | US20110064718 Pesticidal and Antiparasitic Compositions |
| 03/17/2011 | US20110064707 Probiotics to improve gut microbiota |
| 03/17/2011 | US20110064698 Hepatitis c virus inhibitors |
| 03/17/2011 | US20110064697 Hepatitis c virus inhibitors |
| 03/17/2011 | US20110064696 Hepatitis c virus inhibitors |
| 03/17/2011 | US20110064695 Hepatitis c virus inhibitors |
| 03/17/2011 | US20110064694 Anti-hepatitis c activity of meso-tetrakis-porphyrin analogues |
| 03/17/2011 | US20110064693 Antiviral Drugs for Treatment of Arenavirus Infection |
| 03/17/2011 | US20110061649 Device and method for treating respiratory and other diseases |
| 03/17/2011 | CA2773486A1 New vaccine formulations comprising saponin-containing adjuvants |
| 03/17/2011 | CA2772907A1 Selective antibacterials for clostridium difficile infections |
| 03/17/2011 | CA2772786A1 Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl]amino]-n-[3-(4-pyridyl)-1-[2-(4-pyridyl)ethyl]propyl]propanamide and uses thereof |
| 03/17/2011 | CA2772253A1 Modulators of toll-like receptors |
| 03/17/2011 | CA2771124A1 Inhibitors of flaviviridae viruses |
| 03/16/2011 | EP2295465A2 Human monoclonal antibodies to influenza M2 protein and methods of making and using same |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295444A2 Lipopeptides as antibacterial agents |
| 03/16/2011 | EP2295442A2 Inhibitors of interleukin-1beta converting enzyme |
| 03/16/2011 | EP2295441A2 Novel Bicyclonucleoside and Oligonucleotide Analogue |
| 03/16/2011 | EP2295419A2 Substituted tetracycline compounds |
| 03/16/2011 | EP2295413A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295412A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295404A2 Substituted tetracycline compounds |
| 03/16/2011 | EP2295402A2 Antibacterial agents |
| 03/16/2011 | EP2295401A2 Deuterated hepatitis C protease inhibitors |
| 03/16/2011 | EP2295079A2 Method for treating inflammation |
| 03/16/2011 | EP2295078A2 Method for treating inflammation |
| 03/16/2011 | EP2295075A1 Enterohemorragic escherichia coli vaccine |
| 03/16/2011 | EP2295065A1 Modified heat shock protein-antigenic peptide complex |
| 03/16/2011 | EP2295052A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450 |
| 03/16/2011 | EP2295023A1 Flavivirus vaccines |
| 03/16/2011 | EP2294917A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 03/16/2011 | EP2294189A2 The large form of human 2', 5'-oligoadenylate synthetase oas3 for preventing or treating infection with positive-sense single-stranded rna viruses |
| 03/16/2011 | EP2294180A1 Method of reducing motility in bacteria by overexpression of a gene of oi-1 genomic island |
| 03/16/2011 | EP2294084A1 Monoclonal antibodies having homosubtype cross -neutralization properties against influenza a viruses subtype h1 |
| 03/16/2011 | EP2293810A2 Compositions and methods for preventing or treating aids |
| 03/16/2011 | EP2293806A1 Oral herbal composition for the treatment of oral candidiasis |
| 03/16/2011 | EP2293787A1 Nanoemulsions for treating fungal, yeast and mold infections |
| 03/16/2011 | EP2293678A1 Angiogenin-enriched milk fractions |
| 03/16/2011 | EP2293671A1 Small molecule inhibitors for the treatment or prevention of dengue virus infection |
| 03/16/2011 | EP2293670A1 Compositions and methods for nail fungus treatment |
| 03/16/2011 | EP2173756B1 Macrolactone derivatives |
| 03/16/2011 | EP2057165B1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 03/16/2011 | EP1879856B1 Alkyl-, alkenyl- and alkynyl carbamate derivatives, the preparation and therapeutic use thereof |
| 03/16/2011 | EP1830850B1 Quinoline derivatives for the treatment of latent tuberculosis |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | EP1417186B1 Heterocyclic aryl sulphonamides |
| 03/16/2011 | EP1326633B1 Composition comprising immunogenic microparticles |
| 03/16/2011 | EP1298137B1 Novel substance having physiological activity, process for producing the same, and use |
| 03/16/2011 | CN201758886U Health care inner sole |
| 03/16/2011 | CN1810815B Nitroimidazole derivative for treatment |
| 03/16/2011 | CN101985605A Saprolegnia antagonist and application thereof |
| 03/16/2011 | CN101985469A Ruditapes philippinarum big defensin and preparation method and application thereof |
| 03/16/2011 | CN101985457A Medicinal salts of cordycepin and preparation method and medicinal application thereof |
| 03/16/2011 | CN101985454A Novel crystal form of tenofovir ester maleate, preparation method and pharmaceutical application thereof |
| 03/16/2011 | CN101985030A Traditional Chinese medicine for treating herpes zoster |
| 03/16/2011 | CN101985024A Medicinal liquor having stomach harmonizing and channel activating effects |
| 03/16/2011 | CN101984976A Compositions for veterinary and medical applications |
| 03/16/2011 | CN101984975A Medical composition containing cordycepin derivatives |
| 03/16/2011 | CN101984966A New medicinal composition |
| 03/16/2011 | CN101984957A Method for preparing valnemulin salt premix |
| 03/16/2011 | CN101647881B Medicine for treating fever of chicken |
| 03/16/2011 | CN101584671B Cefazedone sodium medicament powder injection and method for synthesizing raw medicine of Cefazedone sodium |
| 03/16/2011 | CN101564524B Traditional Chinese medicine injection for treating canine parvovirus disease and preparation method thereof |
| 03/16/2011 | CN101559063B External medicament for curing herpes zoster and preparation method thereof |
| 03/16/2011 | CN101550111B Preparation method of 2,5-bichlorphenyl-1,3,4-furodiazole |
| 03/16/2011 | CN101530436B Method of effectively extracting ganoderma triterpenoids and ganoderan from mythic fungus germ entity |
| 03/16/2011 | CN101496811B Soluble and stable tilmicosin composition |
| 03/16/2011 | CN101485749B Effervescent tablets for women as well as preparation method and application thereof |
| 03/16/2011 | CN101475651B Preparation of Gracilaria gigas Harvey polysaccharides |
| 03/16/2011 | CN101357228B Preparation method of hepatitis b human immunoglobulin for intravenous injection |
| 03/16/2011 | CN101332256B Traditional Chinese medicine composition for infectious bursal disease and preparation method thereof |
| 03/16/2011 | CN101274066B Chinese medicine composition for tuberculous |
| 03/16/2011 | CN101214252B Antiviral antibacterial medicinal composition and preparation thereof |
| 03/16/2011 | CN101213998B Health care pu'er tea capable of resisting HIV virus and improving human body immunity |
| 03/16/2011 | CN101194944B Technique of preparing medicament for treating upper respiratory tract infection and quality control method |
| 03/16/2011 | CN101129470B Method of preparing the tablet for hepatitis disease |
| 03/16/2011 | CN100999503B Hexanary carbocycle azole like nucleoside analogue, its synthesizing process and use in anti virus and tumor thereof |
| 03/15/2011 | US7906659 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906641 Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof |
| 03/15/2011 | US7906629 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/15/2011 | US7906523 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 03/15/2011 | US7906277 Compound and methods for diagnosis of tuberculosis |
| 03/15/2011 | US7906123 Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof |
| 03/15/2011 | CA2675757C Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 03/15/2011 | CA2613030C Agent for the treatment of herpes virus-derived pain |
| 03/15/2011 | CA2550660C Florfenicol prodrug having improved water solubility |
| 03/15/2011 | CA2544383C Sodium hypochlorite gel composition |
| 03/15/2011 | CA2529062C Antimicrobial polypeptides |